Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net loss	$ (5,409,147)	$ (7,011,580)
Adjustments to reconcile net loss to net cash used in operating activities:
Intangible asset impairment		838,500
Depreciation and amortization	197,555	528,596
Amortization of deferred warrant expense	230,806	99,216
Stock compensation expense	23,053	42,071
Change in assets and liabilities, net of acquisition:
Accounts receivable, net	410,337	1,820,642
Inventories	1,207,800	496,078
Prepaid expenses and other current assets	309,773	(202,892)
Other assets	384,805	(15,935)
Accounts payable	(358,058)	555,832
Accrued compensation and employee benefits	(437,256)	(74,723)
Accrued expenses	(267,234)	(304,136)
Unearned revenue	121,716	86,964
Other liabilities	(315,132)	46,382
Net cash used in operating activities	(3,900,982)	(3,094,985)
Cash flows from investing activities:
Net increase in marketable securities	(393)	(434)
Capital expenditures	(51,566)	(138,443)
Net cash used in investing activities	(51,959)	(138,877)
Cash flows from financing activities:
Revolving credit borrowings	650,000	3,200,000
Net proceeds from rights offering and investment agreement	3,056,981
Net cash provided by financing activities	3,706,981	3,200,000
Effect of exchange rate changes on cash	(50,248)	333,392
Net (decrease) increase in cash	(296,208)	299,530
Cash and cash equivalents at beginning of year	2,253,952	1,954,422
Cash and cash equivalents at end of year	1,957,744	2,253,952
Cash paid during the fiscal year for:
Income taxes		21,751
Interest	411,624	231,113
Non-cash investing and financing activities:
Warrants issued		$ 438,000